APTT

The desired APTT value for a patient receiving heparin therapy depends on the indication for heparin therapy and the specific guidelines of the institution or healthcare provider. Generally, the therapeutic range for APTT in patients receiving heparin therapy is 1.5 to 2.5 times the control value, as determined by the laboratory.

The American College of Cardiology (ACC) provides guidelines for heparin therapy in the treatment of acute coronary syndrome (ACS) and deep vein thrombosis (DVT). For ACS, the recommended target APTT range is 50-70 seconds. For DVT, the recommended target APTT range is 1.5-2.5 times the control value. However, it is important to note that the specific target APTT range may vary depending on the individual patient's medical history, comorbidities, and other factors, and should be determined by the healthcare provider.

It is also worth noting that while APTT is a useful test for monitoring heparin therapy, other factors, such as the patient's clinical response to therapy and the results of other laboratory tests, should be considered when determining the appropriate heparin dosage and monitoring the patient's anticoagulation status.